Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


840 Memorial Drive, 2nd Floor
MA, MA 02139, USA
Cambridge, USA


President & CEO
Vice President, Biology and Translational Research
Vice President, Biophysical and Analytical Technologies
Vice President, Clinical Development
Board Member
Board Member
Board Member
Board Member
Show All People



Aileron Therapeutics

Aileron Therapeutics, based in Cambridge, Massachusetts, is a biopharmaceutical company that was founded in 2005 to develop and advance a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution, or “scaffold” for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The ability to target and regulate these control points affords the unique opportunity to exploit potentially thousands of currently “undruggable” cellular targets with applications in all human diseases.

Aileron’s proprietary technology locks peptides into their biologically active shape, mimicking the structures found in nature, and ultimately endows the peptide with unique properties, including efficient cell penetration, high affinity binding to large target protein surfaces and excellent stability within the body.

Recent Milestones



Aileron Therapeutics screenshot
Above: Aileron Therapeutics Screenshot -- #1
Uploaded: 6/16/09


  1. Aileron scores $7M in new venture funds ( [edit]
  2. Aileron ramps up business on heels of positive results ( [edit]
  3. Aileron Therapeutics Closes Series D Financing ( [edit]
  4. Aileron Therapeutics Raises $12M in Series D Financing ( [edit]
  5. Aileron Therapeutics Secures $30M in Series E Equity Financing ( [edit]
  6. New Roche deal could net Aileron $1.1B ( [edit]
Edit This Page
Last Edited 12/19/13

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy